Clinically, lower circulating levels of Nrg4 are negatively correlated with body mass index (BMI), waist circumference, and the presence of metabolic syndrome, supporting its potential role as both a biomarker and therapeutic target in obesity treatment [84]. This evidence concerns the gene NRG4 and Obesity.